ArticleInternational journal of molecular sciences2022

Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells.

Cynthia M Simbulan-Rosenthal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.